GBT to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020
October 29, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report third quarter 2020 financial results on...
GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia
October 26, 2020 06:00 ET
|
Global Blood Therapeutics, Inc.
Real-world effectiveness data on Oxbryta® (voxelotor) in the treatment of sickle cell disease featured as oral presentation SOUTH SAN FRANCISCO, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Global...
GBT Receives Rare Impact Award for Innovation from the National Organization of Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets
October 12, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) announced today it has received the 2020 Rare Impact Award® for Industry Innovation...
GBT Announces New Employment Inducement Grants
October 05, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on October 1, 2020, the compensation committee of GBT’s board...
GBT and Sickle Cell Disease Association of America to Host 9th Annual Sickle Cell Disease (SCD) Therapeutics Conference
September 09, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
Keynote Address by U.S. Assistant Secretary for Health Admiral Brett P. Giroir, M.D. Discussion to Focus on SCD Treatment Progress and Management During COVID-19 Pandemic SOUTH SAN FRANCISCO,...
GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta® (voxelotor) in Six Middle Eastern Countries
September 08, 2020 16:05 ET
|
Global Blood Therapeutics, Inc.
More than 100,000 people age 12 years and older with sickle cell disease (SCD) in Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates SOUTH SAN FRANCISCO, Calif., Sept. 08, 2020...
GBT Announces New Employment Inducement Grants
September 04, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on September 1, 2020, the compensation committee of GBT’s...
GBT Announces Participation in Upcoming Investor Conferences
September 03, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that members of the senior management team will participate in...
GBT Announces New Employment Inducement Grants
August 07, 2020 08:00 ET
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on August 1, 2020, the compensation committee of GBT’s board...
GBT Reports Recent Business Progress and Second Quarter 2020 Financial Results
August 05, 2020 16:01 ET
|
Global Blood Therapeutics, Inc.
Achieved Oxbryta® (voxelotor) net revenues of $31.5 million, with approximately 1,000 new patient prescriptions Announced plans to seek approval of Oxbryta for younger pediatric patients in the...